- Home
- MREO
as 03-28-2025 4:00pm EST
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
| Founded: | 2015 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | 369.2M | IPO Year: | N/A |
| Target Price: | $7.71 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.29 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.23 - $5.02 | Next Earning Date: | 03-26-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 69.09% |
Latest Mereo BioPharma Group plc News
MREO Breaking Stock News: Dive into MREO Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
JPMorgan Initiates Coverage on Mereo BioPharma Group With Overweight Rating, $7 Price Target
GlobeNewswire
3 days ago
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
Zacks
9 days ago
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock?
Simply Wall St.
18 days ago
Exploring High Growth Tech Stocks In The US Market
GlobeNewswire
24 days ago
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
Life Insurance International
2 months ago
Mereo Insurance forays into reinsurance market
Bloomberg
2 months ago
Ex-AIG Chief Secures $700 Million for Mereo Reinsurance Startup
GlobeNewswire
3 months ago
Mereo BioPharma Provides Update on Lead Clinical Programs
Compare MREO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MREO Mereo BioPharma Group plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.